Insulin Resistance Care Effectiveness in Patients with Schizophrenia A Mixed-Methods Exploration
Received Date: Aug 04, 2022 / Published Date: Aug 28, 2022
Abstract
The prevalence and incidence of Type 2 diabetes have increased dramatically over the last two decades. Saudi Arabia has an estimated two million adults with diabetes, ranking seventh in the world and second in the Middle East.The global prevalence of schizophrenia is percent, with 40 percent of cases remaining untreated [1-15].In Saudi Arabia,the lifetime prevalence of psychological disorders is 34.2 percent. 4 Furthermore, the prevalence of schizophrenia is unknown.
There is a wealth of data indicating that patients with schizophrenia are at least twice as likely as the general population to develop Type 2 diabetes. 5,6 Furthermore, patients with schizophrenia have a higher risk of death, with a life expectancy 13-15 years lower than patients without schizophrenia.
While the exact causes of Type 2 diabetes in patients with schizophrenia are unknown, research suggests that it is a combination of genetics, atypical antipsychotic treatment, the long duration of schizophrenia, an unhealthy lifestyle,and high triglycerides Several studies have looked into undiagnosed Type 2 diabetes in patients with severe mental illness.
Citation: Aloudah NM (2022) Insulin Resistance Care Effectiveness in Patients with Schizophrenia A Mixed-Methods Exploration. Int J Adv Innovat Thoughts Ideas, 11: 183. Doi: 10.4172/2277-1891.1000183
Copyright: © 2022 Aloudah NM. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 716
- [From(publication date): 0-2022 - Jan 29, 2025]
- Breakdown by view type
- HTML page views: 541
- PDF downloads: 175